TIAA CREF INVESTMENT MANAGEMENT LLC 13D and 13G filings for Altimmune, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 11:36 am Sale | 2023-12-31 | 13G | Altimmune, Inc. ALT | TIAA CREF INVESTMENT MANAGEMENT LLC | 1,549,364 2.880% | -1,716,599 (-52.56%) | Filing |
| 2023-04-12 2:55 pm Unchanged | 2022-12-31 | 13G | Altimmune, Inc. ALT | TIAA CREF INVESTMENT MANAGEMENT LLC | 3,265,963 6.640% | 0 (Unchanged) | Filing |
| 2023-02-14 08:46 am Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | TIAA CREF INVESTMENT MANAGEMENT LLC | 3,265,963 7.560% | 1,056,159 (+47.79%) | Filing |
| 2022-02-11 2:37 pm Purchase | 2021-12-31 | 13G | Altimmune, Inc. ALT | TIAA CREF INVESTMENT MANAGEMENT LLC | 2,209,804 5.760% | 2,209,804 (New Position) | Filing |